Awad A, Al-Nafisi H Public knowledge of cardiovascular disease and its risk factors in Kuwait: a cross-sectional survey. BMC Public Health. 2014 Nov 4;14:1131. doi: 10.1186/1471-2458-14-1131.
Beatty AL, Fukuoka Y, Whooley MA Using mobile technology for cardiac rehabilitation: a review and framework for development and evaluation. J Am Heart Assoc. 2013 Nov 1;2(6):e000568. doi: 10.1161/JAHA.113.000568. Review.
Chomutare T, Fernandez-Luque L, Arsand E, Hartvigsen G Features of mobile diabetes applications: review of the literature and analysis of current applications compared against evidence-based guidelines. J Med Internet Res. 2011 Sep 22;13(3):e65. doi: 10.2196/jmir.1874. Review.
Ghanem F A., & Movahed A. (2009). Prevention of Coronary Heart Disease. In Movahed, A., Gnanasegaran, G., Buscombe, J., & Hall, M. Integrating Cardiology for Nuclear Medicine Physicians. Springer Berlin Heidelberg. P. 419-423.
Gough D (2011). Coronary heart disease. Practice Nurse 41(1), 12-17
Ministry of Health (2014) Health Matters. Retrieved from ttp://mohsingapore.sg/2012/02/living-healthily/ January. 2014.
Ministry of Health Singapore (2014) Principal Causes of Death 2013; Available from: http://www.moh.gov.sg/content/moh_web/home/statistics/Health_Facts_Singapore/Principal_Causes_of_Death.html.
Peck AD One-touch access to a world of resources: mobile health apps streamline workflows. Med Econ. 2011 Sep 10;88(17):S7-8, S10-1.
Pierannunzi C, Hu SS, Balluz L A systematic review of publications assessing reliability and validity of the Behavioral Risk Factor Surveillance System (BRFSS), 2004-2011. BMC Med Res Methodol. 2013 Mar 24;13:49. doi: 10.1186/1471-2288-13-49. Review.
Polit D F., & Beck C. T (2014). Essentials of Nursing Research: Methods, Appraisal, and Utilization. 8th edn. Philadelphia: Lippincott.
Sim J, Lewis M The size of a pilot study for a clinical trial should be calculated in relation to considerations of precision and efficiency. J Clin Epidemiol. 2012 Mar;65(3):301-8. doi: 10.1016/j.jclinepi.2011.07.011. Epub 2011 Dec 9.
Singapore Heart Foundation (2011) Deaths from Cardiovascular Disease. Retrieved from http://www.myheart.org.sg/heart-facts/statistics/ Oct. 2011.
Singapore Heart Foundation (2014) Heart4Life Phase 1. Retrieved from http://www.myheart.org.sg/article/heart-safe-singapore/heart4life-mobile-app/about/186/ January 2014.
Smeltzer S C., Bare B. G., Hinkle J. L., & Cheever K. H. (2010). Brunner & Suddarth's textbook of medical surgical nursing 12th edn. Wallnut Street, Philadelphia: PA.
Wagner J, Lacey K, Chyun D, Abbott G Development of a questionnaire to measure heart disease risk knowledge in people with diabetes: the Heart Disease Fact Questionnaire. Patient Educ Couns. 2005 Jul;58(1):82-7.
World Health Organization (2014) The top 10 causes of death. (Fact sheet No. 310). Retrieved from: http://www.who.int/mediacentre/factsheets/fs310/en/
Improving Awareness, Knowledge and Heart-related Lifestyle of Coronary Heart Disease Among Working Population Through a mHealth Programme
Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.
Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.
Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.
Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.
Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.
